Funding for this research was provided by:
Gemeinsame Gesundheitsziele aus dem Rahmen-Pharmavertrag/Pharma Master Agreement (99901006800)
Received: 15 October 2020
Accepted: 22 February 2021
First Online: 8 March 2021
Ethics approval and consent to participate
: Ethical approval was obtained from the Ethics Committee of the Medical University of Vienna (EK 2005/2017). The data collection in this study follows the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. The trial was registered at clinicaltrials.gov (Identifier: NCT03535714). The ethics commission will be notified in case of any amendments to the study protocol. Written informed consent from one of the legal representatives (if aged below 18) and patient’s assent are obtained prior to the inclusion in the study. The informed consent form can be requested from the corresponding author.
: Not applicable.
: The authors declare that they have no competing interests.